Arrowhead Pharmaceuticals ARWR
NASDAQ ARWR
$64.31 -0.48 (-0.74%)
As of: Oct 2, 2026 · 3:02 PM EDT

Arrowhead Pharmaceuticals (ARWR) Return on Assets [ROA] (2011 - 2026)

Updated

Arrowhead Pharmaceuticals' Return on Assets [ROA] came in at -12.43% for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 1.64 percentage points from -10.79% a year earlier but up 1.62 percentage points from the prior quarter.

Analysis

Arrowhead Pharmaceuticals (ARWR) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Arrowhead Pharmaceuticals' Return on Assets [ROA] was 2.39%, up 66.38 percentage points from FY2024.

  • Return on Assets [ROA] carries a five-year change of +21.77 percentage points (FY2020 to FY2025).
  • Going back by fiscal year, Return on Assets [ROA] was -64.00% in FY2024 (-35.28 pp), -28.72% in FY2023 (-3.54 pp), -25.18% in FY2022 (-2.32 pp) and -22.85% in FY2021 (-3.47 pp).
  • The five-year range for quarterly Return on Assets [ROA] is -60.39% (fiscal Q2 2024) to 15.63% (fiscal Q1 2026).
  • Year-over-year, Return on Assets [ROA] increased in four of the last eight quarters, with an average year-over-year change of +22.70 percentage points.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in fiscal Q1 2026 (a gain of 75.95 percentage points), and the weakest in fiscal Q2 2024 (a drop of 43.32 percentage points).
  • Business Quant data shows ARWR's Return on Assets [ROA] at -14.04% (Q2 2026), 15.63% (Q1 2026) and 2.18% (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Arrowhead Pharmaceuticals 9.24 Bn 4.02 Bn - -12.43%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -12.43%
Mar 31, 2026 -14.04%
Dec 31, 2025 15.63%
Sep 30, 2025 2.18%
Jun 30, 2025 -10.79%
Mar 31, 2025 -11.96%
Dec 31, 2024 -60.32%
Sep 30, 2024 -60.26%
Jun 30, 2024 -59.53%
Mar 31, 2024 -60.39%
Dec 31, 2023 -43.52%
Sep 30, 2023 -26.81%
Jun 30, 2023 -21.84%
Mar 31, 2023 -17.07%
Dec 31, 2022 -19.63%
Sep 30, 2022 -24.45%
Jun 30, 2022 -21.15%
Mar 31, 2022 -16.66%
Dec 31, 2021 -27.14%
Sep 30, 2021 -19.49%
API Access

Arrowhead Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ARWR&period=max&api_key=YOUR_API_KEY